GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (MEX:GH) » Definitions » Net Margin %

Guardant Health (MEX:GH) Net Margin % : -55.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Guardant Health Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Guardant Health's Net Income for the three months ended in Dec. 2024 was MXN-2,315 Mil. Guardant Health's Revenue for the three months ended in Dec. 2024 was MXN4,209 Mil. Therefore, Guardant Health's net margin for the quarter that ended in Dec. 2024 was -55.00%.

The historical rank and industry rank for Guardant Health's Net Margin % or its related term are showing as below:

MEX:GH' s Net Margin % Range Over the Past 10 Years
Min: -182.74   Med: -93.85   Max: -35.29
Current: -59.05


MEX:GH's Net Margin % is ranked worse than
70.7% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.46 vs MEX:GH: -59.05

Guardant Health Net Margin % Historical Data

The historical data trend for Guardant Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Net Margin % Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only -88.51 -108.57 -145.61 -85.02 -59.05

Guardant Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.63 -68.24 -57.91 -56.28 -55.00

Competitive Comparison of Guardant Health's Net Margin %

For the Diagnostics & Research subindustry, Guardant Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardant Health's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where Guardant Health's Net Margin % falls into.


;
;

Guardant Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Guardant Health's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-9100.864/15412.696
=-59.05 %

Guardant Health's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-2315.108/4208.972
=-55.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guardant Health  (MEX:GH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Guardant Health Net Margin % Related Terms

Thank you for viewing the detailed overview of Guardant Health's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guardant Health Business Description

Traded in Other Exchanges
Address
3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.